Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Lexicon Pharmaceuticals, Inc.
(NQ:
LXRX
)
2.190
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Lexicon Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
February 23, 2012
from
PR Newswire
Lexicon Pharmaceuticals (LXRX) Reports Mixed Q4 Results
February 22, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7200986 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial Results
February 22, 2012
Conference Call and Webcast at 11:00 a.m. Eastern Time
Read More
from
PR Newswire
Trading Radar for 02/22: MGM Resorts (MGM), Hewlett-Packard (HPQ), Zale (ZLC), Analog Devices (ALOG) Report
February 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7200237 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
February 16, 2012
Conference Call and Webcast to Follow
Read More
from
PR Newswire
Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
February 07, 2012
from
PR Newswire
Higher Close On Upbeat Economic Data
January 19, 2012
Falling jobless claims and record low mortgage rates lifted the markets to a higher close with the Dow climbing 46 points to 12,625. Nasdaq gained 18 points to 2788.
Read More
category
Market News
from
MarketMinute.com Market Updates
Stock to Watch: Lexicon Pharmaceuticals Up 7.5% (LXRX)
January 17, 2012
from
Comtex SmarTrend® News Briefs
Pre-Open Movers 1/10: (REGN) (ELX) (CRUS) Higher; (WBMD) (LIZ) (TIF) Lower (more...)
January 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7071347 for the full story.
Read More
from
StreetInsider.com News Articles
After-Hours Movers 01/09: (LXRX) (ELX) (CRUS) Higher; (LIZ) (WDFC) (SMSC) (TRNO) (JNPR) Lower
January 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7069774 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
January 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7069235 for the full story.
Read More
from
StreetInsider.com News Articles
LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 Diabetes
January 09, 2012
Combination of LX4211 and DPP-4 Inhibitor Reduces Blood Sugar After Meals and Increases GLP-1 in Type 2 Diabetic Patients More than DPP-4 Inhibitor Alone
Read More
from
PR Newswire
Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); 2012 Preview: Several Key Clinical Milestones Anticipated
January 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7064038 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
January 04, 2012
from
PR Newswire
Lower Close With Europe Mired In Debt
December 30, 2011
The markets ended the year flat with Europe mired in debt and the domestic job market just beginning to show some signs of recovery. The Dow fell 69 points to close the year at 12,217 while Nasdaq lost...
Read More
category
Market News
from
MarketMinute.com Market Updates
Lexicon Pharmaceuticals (LXRX) Completes Offering with Gross Proceeds of $161 Million
December 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7041228 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Announces Completion of Rights Offering to Stockholders
December 23, 2011
from
PR Newswire
Needham & Company 2012 Biotech Preview
December 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7041126 for the full story.
Read More
from
StreetInsider.com News Articles
FMR LLC Raises Stake in Lexicon Pharmaceuticals, Inc. (LXRX) to 17.55%
December 12, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7012346 for the full story.
Read More
from
StreetInsider.com News Articles
Biotech/ Pharma Stocks To Watch; Friday's Gainers: (NASDAQ:PARDD), (NASDAQ:LXRX), (NASDAQ:ACHN), (NASDAQ:TNGN)
December 12, 2011
Point Roberts, WA - December 12, 2011- Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues an investor alert for some of the top...
Read More
category
NASDAQ:LXRX
,
NASDAQ:PARDD
,
NASDAQ:TNGN
, and 1 more.
from
Investorideas.com newswire, stock news and business news for investors
Hot Stock: Lexicon Pharmaceuticals, Shares Drop 0.0% (LXRX)
November 22, 2011
from
Comtex SmarTrend® News Briefs
Lexicon Pharma (LXRX) Commences 144.25M Common Rights Offering
November 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6969155 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Announces Commencement of Rights Offering to Stockholders
November 22, 2011
from
PR Newswire
Lexicon Announces Plans for Rights Offering to Stockholders
November 11, 2011
from
PR Newswire
Lexicon (LXRX) to Present Favorable Data from LX2931 Phase 2a in RA Patients
November 09, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6928641 for the full story.
Read More
from
StreetInsider.com News Articles
LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
November 09, 2011
from
PR Newswire
Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
November 03, 2011
from
PR Newswire
Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); Q3 Review
November 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6904843 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Tops Q3 EPS by 1c
November 01, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6898872 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
November 01, 2011
Conference Call and Webcast at 11:00 a.m. Eastern Time
Read More
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here